Zham Poonam, Poosapadi Sridhar A, Kempster Peter, Raghav Sanjay, Nagao Kanae J, Wong Kitty, Kumar Dinesh
School of Engineering, RMIT University, Melbourne, VIC, Australia.
IBM Research Australia, Southbank, VIC, Australia.
Front Neurol. 2021 May 11;12:665112. doi: 10.3389/fneur.2021.665112. eCollection 2021.
Micrographia, one element of the dysgraphia of Parkinson's disease (PD), may be classified according to the presence or absence of a decremental pattern. The decremental form, progressive micrographia, is an expression of the sequence effect seen generally in bradykinesia. Its responsiveness to levodopa has not been evaluated kinematically. Aim of this study is to investigate the difference in levodopa response for progressive and non-progressive micrographia. Twenty-four PD patients and 24 age-matched repeatedly wrote the letter e on a computerized digital tablet. PD patients performed the task two times, in a defined off state and again after levodopa. Scripts were classified as progressive micrographia (PD) or non-progressive micrographia (PD) depending on whether a 10% decrement was seen between the first and final characters of a line of lettering. While levodopa produced a similar response on the MDS-UPDRS motor scale for the two groups, the effect on the two types of micrographia was different. While writing speed improved significantly in both groups after levodopa, the responses were over twofold greater for PD Moreover, the decremental features of PD-in size, speed, and pen-pressure-were largely unaltered by a levodopa dose. Progressive micrographia is less responsive to levodopa. Our findings agree with research showing that the sequence effect of bradykinesia is relatively resistant to medication. Yet we did not find a weaker overall levodopa motor benefit. Caution is needed in the interpretation of such micrographia measurements for estimating drug responses.
小写症是帕金森病(PD)书写障碍的一个要素,可根据是否存在递减模式进行分类。递减型,即进行性小写症,是通常在运动迟缓中见到的序列效应的一种表现。其对左旋多巴的反应尚未从运动学角度进行评估。本研究的目的是调查进行性和非进行性小写症对左旋多巴反应的差异。24名帕金森病患者和24名年龄匹配者在电脑数字化数位板上反复书写字母e。帕金森病患者在明确的关期状态下执行该任务两次,服用左旋多巴后再次执行。根据一行字母的第一个和最后一个字符之间是否出现10%的递减,笔迹被分类为进行性小写症(PD)或非进行性小写症(PD)。虽然左旋多巴对两组患者的MDS-UPDRS运动量表产生了类似的反应,但对两种类型小写症的影响不同。虽然两组患者服用左旋多巴后书写速度均显著提高,但对进行性小写症患者的反应要高出两倍多。此外,进行性小写症在大小、速度和笔压方面的递减特征在很大程度上不受左旋多巴剂量的影响。进行性小写症对左旋多巴的反应较小。我们的研究结果与表明运动迟缓的序列效应相对耐药的研究一致。然而,我们并未发现左旋多巴对运动的总体益处较弱。在解释此类小写症测量结果以估计药物反应时需要谨慎。